Sun Pharmaceutical Industries share news, announcements and annual reports
NSE: SUNPHARMABSE: 524715Pharmaceuticals & BiotechnologyLarge Cap
Sun Pharmaceutical Industries Limited · Formerly Sun Pharmaceuticals Industries · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994 on BSE, Feb 1995 on NSE
Last close ₹1,777.70up ₹16.70 (0.95%)BSE ₹1,778.25
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,761.00.
30 Oct: open ₹1,769.00, high ₹1,855.00, low ₹1,766.20
52-week range of traded prices to 30 Oct 2026
₹1,583.70Low, 29 Jan 2026₹2,046.90High, 31 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,26,530 Cr13th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.90
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1,962 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 32.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1,962 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 15.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 16.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 51,30,21833.2% delivered
Sun Pharmaceutical Industries board meetings
110 filed, newest first. Page 3 of 3.
Oct 2008
15 Oct · Board meeting
Interalia, to consider and take on record the unaudited financial results of the Company for the half year / second quarter ended September 30, 2008.
Jul 2008
14 Jul · Board meeting
Meeting on 28 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
May 2008
20 May · Board meeting
Interalia, (1) to consider the audited financial results of the Company for the year ended March 31, 2008. (2) to consider recommendation of payment of dividend on equity shares for the year ended March 31, 2008 subject to the approval of the shareholders at the ensuing Annual General Meeting.
Jan 2008
16 Jan · Board meeting
Interalia, to consider and take on record the un-audited financial results of the Company for the third quarter ended December 31, 2007.
Oct 2007
9 Oct · Board meeting
Interalia, (i) to consider and take on record the un-audited financial results of the Company for the half year / second quarter ended September 30, 2007. (ii) to consider payment of interim dividend @ 6% p.a. on outstanding 1,37,40,030 Preference Shares of Re.1/- each to those Preference shareholders holding Preference Shares as on November 01, 2007 on prorata basis for the period from April 01, 2007 to November 01, 2007 i.e. the date of compulsory redemption by the Company.
Jul 2007
11 Jul · Board meeting
Meeting on 23 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
May 2007
14 May · Board meeting
Company had informed the Exchange regarding a Board Meeting scheduled to be held on May 15, 2007. The company has now informed the Exchange that: "The proposed Meeting of the Board of Directors of the Company which was to be held on Tuesday, 15th May, 2007, interalia, to consider the audited financial results of the Company for the year ended 31st March, 2007 has been postponed and will now be held on Friday, 18th May 2007".
Apr 2007
30 Apr · Board meeting
Interalia, to consider the audited financial results of the Company for the year ended March 31, 2007.
Mar 2007
2 Mar · Board meeting
Interalia, to consider payment of Interim Dividend on outstanding Preference Shares of Re.1/- each and on Equity Shares of Rs.5/- each for the year ending March 31, 2007. The Preference and the Equity Shareholders of the Company holding shares as on March 16, 2007, being the Record Date, will be eligible to receive such Interim Dividend as may be declared by the board at the above Meeting.
Jan 2007
15 Jan · Board meeting
Meeting on 29 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”